We previously identified NEK4 as a target in squamous cell carcinoma (19), and others have found that it may impact colorectal cancer progression (23), whereas high expression of NEK4 promotes patient survival in clear cell renal cell carcinoma (18). The gene discussed is NEK4; the disease is colorectal cancer.